| Literature DB >> 33021687 |
Filippo Migliorini1, Jörg Eschweiler2, Alice Baroncini2, Markus Tingart2, Nicola Maffulli3,4,5.
Abstract
PURPOSE: Minimally invasive surgery (MIS) for total knee arthroplasty (TKA) is often marketed as being able to speed up healing times over standard invasive surgery (SIS) through the medial parapatellar approach. The advantages of these minimally invasive approaches, however, are not yet definitively established. A meta-analysis of studies comparing peri-operative and post-operative differences and long-term complications of MIS versus SIS for TKA was conducted.Entities:
Keywords: Minimally invasive surgery; Standard invasive surgery; Total knee arthroplasty
Mesh:
Year: 2020 PMID: 33021687 PMCID: PMC8514366 DOI: 10.1007/s00167-020-06306-9
Source DB: PubMed Journal: Knee Surg Sports Traumatol Arthrosc ISSN: 0942-2056 Impact factor: 4.342
Fig. 1Flow-chart of the literature search
PEDro methodological assessment score
| Author | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aslam et al. 2017 [ | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | 10 |
| Avci et al. 2013 [ | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Boerger et al. 2005 [ | Y | N | N | Y | N | N | N | N | Y | Y | Y | 5 |
| Bridgman et al. 2009 [ | Y | Y | Y | Y | N | N | Y | Y | Y | Y | Y | 9 |
| Chalidis et al. 2010 [ | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | 8 |
| Chiang et al. 2012 [ | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | 10 |
| Cho et al. 2014 [ | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | 8 |
| Dabboussi et al. 2012 [ | Y | N | N | Y | N | N | N | N | Y | Y | Y | 5 |
| Feczko et al. 2016 [ | Y | Y | Y | Y | N | N | N | N | Y | Y | Y | 7 |
| Han et al. 2008 [ | Y | Y | Y | Y | N | N | Y | Y | Y | Y | Y | 9 |
| Hernandez-Vaquero et al. 2010 [ | Y | Y | Y | Y | N | N | N | N | Y | Y | Y | 7 |
| Huang et al. 2015 [ | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Jung et al. 2009 [ | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Juosponis et al. 2009 [ | Y | Y | Y | Y | N | N | Y | N | Y | Y | Y | 8 |
| Karachalios et al. 2008 [ | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | 8 |
| Karpman et al. 2009 [ | Y | Y | Y | Y | N | N | Y | N | Y | Y | Y | 8 |
| Kim et al. 2011 [ | Y | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | 10 |
| King et al. 2007 [ | Y | N | N | Y | N | N | N | N | Y | Y | Y | 5 |
| Laskin et al. 2004 [ | Y | N | N | Y | N | N | N | N | Y | Y | Y | 5 |
| Li et al. 2017 [ | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | 8 |
| Liebensteiner et al. 2012 [ | Y | N | N | Y | N | N | N | N | Y | Y | Y | 5 |
| Mehta et al. 2017 [ | Y | Y | Y | Y | N | N | N | N | Y | Y | Y | 7 |
| Rahman et al. 2015 [ | Y | N | N | Y | N | N | N | N | Y | Y | Y | 5 |
| Schroer et al. 2008 [ | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Seon et al. 2007 [ | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Stevens-Lapsley et al. 2012 [ | Y | Y | Y | Y | N | N | Y | N | Y | Y | Y | 8 |
| Tasker et al. 2014 [ | Y | Y | Y | Y | N | N | Y | Y | Y | Y | Y | 8 |
| Tenholder et al. 2005 [ | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Thienpont et al. 2013 [ | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | 8 |
| Tsuji et al. 2010 [ | Y | N | N | Y | N | N | N | N | Y | Y | Y | 5 |
| Unnanuntana et al. 2012 [ | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Unwin et al. 2017 [ | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | 8 |
| Varela-Egocheaga et al. 2009 [ | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | 8 |
| Watanabe et al. 2009 [ | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
| Wegrzyn et al. 2013 [ | Y | Y | Y | Y | Y | N | Y | N | Y | Y | Y | 10 |
| Wülker et al. 2010 [ | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | 8 |
| Zhu et al. 2015 [ | Y | N | N | Y | N | N | N | Y | Y | Y | Y | 6 |
1. Eligibility criteria; 2. Random allocation; 3. Concealed allocation; 4. Baseline comparability; 5. Blind subject; 6. Blind clinician; 7. Blind assessor; 8. Adequate follow-up; 9. Intention-to-treat analysis; 10. Between-group analysis; 11. Point estimates and variability
Fig. 2Funnel plot of the most reported outcome, surgical duration
Study generalities and demographic baseline of the enrolled patients
| Author, year | Type of Study | Knees ( | Follow-up (months) | Type of approach | Knees ( | Osteoarthritis (%) | Female (%) | Mean age (years) | BMI (kg/m2) |
|---|---|---|---|---|---|---|---|---|---|
| Aslam et al. 2017 [ | RCT | 84 | 12 | MMV | 42 | 100 | 30 | 68.8 | 30.6 |
| MPP | 42 | 100 | 57 | 68.6 | 30.1 | ||||
| Avci et al. 2013 [ | RCT | 39 | 23.5 | MMV | 19 | 100 | 79 | 64.5 | 32.0 |
| Boerger et al. 2005 [ | n-RCT | 120 | 3 | MSV | 60 | 100 | 77 | 69.0 | 28.0 |
| MPP | 60 | 100 | 75 | 68.0 | 29.0 | ||||
| Bridgman et al. 2009 [ | RCT | 224 | 13 | MSV | 113 | 48 | 70.1 | ||
| MPP | 111 | 49 | 70.9 | ||||||
| Chalidis et al. 2010 [ | RCT | 100 | 24 | MMV | 50 | 100 | 92 | 70.1 | 34.6 |
| MPP | 50 | 100 | 88 | 71.2 | 34.2 | ||||
| Chiang et al. 2012 [ | RCT | 75 | 24 | QS | 38 | 100 | 90 | 69.7 | 28.6 |
| MPP | 37 | 100 | 90 | 69.8 | 29.6 | ||||
| Cho et al. 2014 [ | RCT | 66 | 12 | MMV | 33 | 100 | 96 | 65.5 | 29.1 |
| MPP | 33 | 100 | 94 | 67.0 | 28.0 | ||||
| Dabboussi et al. 2012 [ | n-RCT | 80 | 3 | MMV | 40 | 100 | |||
| MPP | 40 | 100 | |||||||
| Feczko et al. 2016 [ | RCT | 69 | 6 | MMV | 36 | 95 | 64 | 65.1 | 28.3 |
| MPP | 33 | 100 | 67 | 64.9 | 28.6 | ||||
| Han et al.2008 [ | RCT | 30 | 24 | MMPP | 15 | 100 | 66.0 | 26.9 | |
| MPP | 15 | 100 | 64.0 | 26.4 | |||||
| Hernandez-Vaquero et al. 2010 [ | RCT | 62 | 6 | MMV | 26 | 100 | 81 | 70.8 | 32.1 |
| MPP | 36 | 100 | 80 | 70.5 | 30.8 | ||||
| Huang et al. 2015 [ | n-RCT | 96 | 60 | MMPP | 35 | 100 | 86 | 69.2 | 27.0 |
| QS | 31 | 100 | 94 | 69.3 | 26.9 | ||||
| MPP | 30 | 100 | 93 | 71.2 | 26.7 | ||||
| Jung et al.2009 [ | n-RCT | 40 | 58.4 | MSV | 21 | ||||
| MPP | 19 | ||||||||
| Juosponis et al. 2009 [ | RCT | 70 | 3 | MMV | 35 | 100 | 86 | 72.0 | 28.0 |
| MPP | 35 | 100 | 86 | 71.4 | 29.1 | ||||
| Karachalios et al. 2008 [ | RCT | 100 | 23 | MMV | 50 | 92 | 62 | 71.1 | 32.0 |
| MPP | 50 | 92 | 70 | 70.8 | 31.5 | ||||
| Karpman et al. 2009 [ | RCT | 59 | 6 | MMV | 20 | 100 | 65 | 74.0 | 30.0 |
| QS | 20 | 100 | 60 | 73.0 | 28.0 | ||||
| MPP | 19 | 100 | 53 | 73.0 | 29.0 | ||||
| Kim et al. 2011 [ | RCT | 50 | 12 | MMV | 23 | 100 | 67.0 | 27.1 | |
| MPP | 22 | 100 | 68.0 | 28.4 | |||||
| King et al. 2007 [ | n-RCT | 150 | 1.5 | QS | 100 | 95 | 52 | 67.0 | 30.0 |
| MPP | 50 | 90 | 66 | 28.0 | 32.0 | ||||
| Laskin et al. 2004 [ | n-RCT | 58 | 3 | MMV | 26 | 70.0 | 30.0 | ||
| MPP | 26 | 68.0 | 29.0 | ||||||
| Li et al. 2017 [ | RCT | 50 | 12 | MSV | 25 | 100 | 64 | 69.9 | 25.8 |
| MPP | 25 | 100 | 64 | 68.1 | 25.5 | ||||
| Liebensteiner et al. 2012 [ | n-RCT | 38 | 2 | MMV | 19 | 58 | 66.7 | 30.2 | |
| MPP | 19 | 53 | 67.6 | 31.5 | |||||
| Mehta et al. 2017 [ | RCT | 55 | 6 | MSV/MMV | 26 | 73 | 59.8 | ||
| MPP | 29 | 73 | 61.4 | ||||||
| Rahman et al. 2015 [ | n-RCT | 120 | 3 | MMPP | 60 | 100 | 75 | 59.8 | |
| MPP | 60 | 100 | 77 | 62.0 | |||||
| Schroer et al. 2008 [ | n-RCT | 300 | 24 | QS | 150 | 62 | 71.0 | 31.0 | |
| MPP | 150 | 61 | 70.0 | 32.0 | |||||
| Seon et al. 2007 [ | n-RCT | 84 | 12 | MMV | 41 | 100 | 80 | 64.2 | |
| MPP | 43 | 100 | 77 | 64.2 | |||||
| Stevens-Lapsley et al. 2012 [ | RCT | 41 | 3 | MMPP | 22 | 100 | 54 | 64.6 | 30.5 |
| MPP | 19 | 45 | 64.0 | 31.3 | |||||
| Tasker et al. 2014 [ | RCT | 83 | 24 | MMV/MSV | 40 | 45 | 63 | 67.3 | |
| MPP | 43 | 99 | 63 | 68.2 | |||||
| Tenholder et al. 2005 [ | n-RCT | 118 | MMPP | 69 | 56 | 66.8 | 29.3 | ||
| MPP | 49 | 47 | 63.5 | 31.5 | |||||
| Thienpont et al. 2013 [ | RCT | 300 | 24 | MMPP | 150 | 100 | 67 | 68.0 | 30.4 |
| MPP | 150 | 100 | 70 | 69.0 | 29.8 | ||||
| Tsuji et al. 2010 [ | n-RCT | 20 | 0.5 | MMV | 10 | 100 | 60 | 68.4 | 28.1 |
| MPP | 10 | 100 | 80 | 69.8 | 28.9 | ||||
| Unnanuntana et al. 2012 [ | n-RCT | 64 | 60 | MMPP | 31 | ||||
| MPP | 29 | ||||||||
| Unwin et al. 2017 [ | RCT | 66 | 72 | MMV/MSV | 32 | 76 | 67.0 | ||
| MPP | 34 | 76 | 67.0 | ||||||
| Varela-Egocheaga et al. 2009 [ | RCT | 100 | 36 | MSV | 50 | 72 | 68.0 | 31.0 | |
| MPP | 50 | 74 | 70.6 | 30.6 | |||||
| Watanabe et al. 2009 [ | n-RCT | 48 | 48 | MMV | 25 | 84 | 80 | 71.0 | 28.1 |
| MPP | 23 | 78 | 74 | 71.0 | 26.3 | ||||
| Wegrzyn et al. 2013 [ | RCT | 36 | 2 | MSV | 18 | 100 | 72 | 67.0 | 30.0 |
| MPP | 18 | 100 | 72 | 64.0 | 31.0 | ||||
| Wülker et al. 2010 [ | RCT | 134 | 12 | MSV | 66 | 92 | 73 | 70.2 | 29.3 |
| MPP | 68 | 88 | 70 | 29.3 | |||||
| Zhu et al. 2015 [ | n-RCT | 67 | 109.2 | MMPP | 30 | 93 | 67.9 | 27.6 | |
| MPP | 37 | 84 | 65.3 | 27.7 |
MMV mini-midvastus, MSV mini-subvastus, QS quadriceps-sparing, MMPP mini-medial parapatellar, MPP medial parapatellar
Demographic baseline of the two cohorts
| Variable | MIS ( | SIS ( | |
|---|---|---|---|
| Age (mean SD) | 68.4 ± 2.8 | 67.7 ± 2.7 | 0.8 |
| Female gender (%) | 67% | 67% | 0.9 |
| BMI (kg/m2) | 29.4 ± 1.7 | 29.2 ± 1.8 | 0.9 |
| OA patients (%) | 97% | 99% | 0.9 |
Fig. 3Forest plot of the comparison surgical duration
Fig. 4Forest plot of the comparison hospitalization length
Fig. 5Forest plot of the comparison range of motion
Fig. 6Forest plot of the comparison revision
Main results of the comparisons
| Outcome | Studies ( | Knees ( | MIS (mean ± SD) | SIS (mean ± SD) | Effect estimate, MD [95% CI] | |
|---|---|---|---|---|---|---|
| Hospitalization length | 15 | 1547 | 5.10 ± 2.4 | 6.71 ± 2.3 | − 1.31 [− 2.23, − 0.39] | 0.005 |
| Surgical duration | 23 | 2077 | 86.97 ± 20.2 | 75.69 ± 14.3 | 15.51 [9.79, 21.23] | < 0.0001 |
| Total estimated blood loss | 19 | 1499 | 601.23 ± 197.8 | 680.14 ± 300.6 | − 76.88 [− 183.35, 29.58] | 0.006 |
| Straight-Leg Raise | 6 | 630 | 2.12 ± 0.8 | 3.77 ± 1.9 | − 1.47 [− 2.89, − 0.05] | 0.04 |
| ROM | 14 | 1127 | 117.06 ± 10.8 | 113.71 ± 11.8 | 2.89 [0.15, 5.64] | 0.04 |
| Flexion | 8 | 722 | 107.14 ± 11.6 | 104.79 ± 15.8 | 5.92 [3.26, 8.57] | < 0.0001 |
| KSS | 15 | 1411 | 89.69 ± 4.8 | 86.21 ± 5.5 | 1.09 [0.55, 1.64] | < 0.0001 |
| KSFS | 9 | 963 | 79.13 ± 3.5 | 75.41 ± 4.8 | 3.07 [− 1.08, 7.21] | 0.01 |
| VAS | 8 | 738 | 2.12 ± 0.6 | 2.62 ± 1.2 | − 9.25 [− 20.65, 2.14] | 0.1 |
Complications
| Outcome | Studies ( | Knees ( | MIS (events) | SIS (events) | Effect estimate, OR [95% CI] | |
|---|---|---|---|---|---|---|
| Anterior knee pain (OR) | 2 | 169 | 21/258 | 14/249 | 3.54 [0.71, 17.55] | 0.1 |
| Revision surgery (OR) | 10 | 1116 | 14/565 | 15/551 | 0.93 [0.47, 1.87] | 0.9 |